{\rtf1\ansi\ansicpg1252\cocoartf2822
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 Practitioner_Name,Client_ID,Treatment_Date,Patient_Age,Patient_Sex,Focus_Area,Chemical_Used,Dosage_Mg,Intake_Form,Protocol_Description,Treatment_Outcome_Rating,Detailed_Results,Next_Steps\
Clinician D. Allen,P-5006,2025-09-25,37,M,Spirituality,DMT,26,Inhaled,Used a controlled setting with breath coaching and a structured integration conversation.,1,Patient had elevated agitation and required extended grounding and follow up support.,Medical review scheduled and treatment paused pending reassessment.\
Dr. M. Hernandez,P-1458,2025-05-26,34,M,Addiction,Psilocybin,23,Drank,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,3,Patient reported some insight but noted moderate anxiety during the peak which required coaching. Patient remained engaged and completed integration homework.,Coordinate with primary therapist and reassess in 3 weeks.\
Dr. S. Kim,P-2421,2025-08-08,50,M,Addiction,Other,52,Drank,Applied a structured session with symptom tracking and a follow up integration appointment.,2,Patient reported minimal psychological effect and felt frustrated afterward.,Discuss alternative protocol and review safety plan at next visit.\
Clinician B. Jones,P-1378,2025-05-03,54,M,PTSD,Ketamine,97,Other,Used a low stimulation room with guided imagery and a next day integration appointment.,4,Patient reported reduced hypervigilance and improved sleep over the next week. No adverse effects reported beyond transient fatigue.,Follow up in 2 weeks to review symptoms and plan next session.\
Dr. A. Smith,P-4622,2025-02-10,56,F,PTSD,Psilocybin,18,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,3,Patient reported mild nausea and fatigue which limited depth of processing.,Coordinate with primary therapist and reassess in 3 weeks.\
Dr. E. Chen,P-6086,2025-10-14,40,F,General Personal Health,Other,34,Injected,Applied a structured session with symptom tracking and a follow up integration appointment.,4,Patient described reduced stress reactivity and clearer priorities for self care.,Integration session scheduled in 7 days.\
Dr. K. Johnson,P-5744,2025-03-22,29,M,PTSD,Ketamine,112,Injected,Used a monitored ketamine assisted psychotherapy session with vital sign checks and integration afterward.,5,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward.,Integration session scheduled in 7 days.\
Clinician C. Rivera,P-4244,2025-04-19,65,F,General Personal Health,Other,103,Eaten,Used a supportive coaching session paired with a standardized preparation and integration plan.,3,Patient described partial benefit but felt distracted and had difficulty sustaining focus.,Adjust dose and repeat in 4 weeks if clinically appropriate.\
Dr. S. Kim,P-8794,2025-06-01,68,F,PTSD,Psilocybin,34,Eaten,Used a single day guided session with eyeshades and a curated music playlist.,4,Patient noted fewer intrusive thoughts and a calmer baseline mood. No adverse effects reported beyond transient fatigue.,Follow up in 2 weeks to review symptoms and plan next session.\
Dr. T. O'Connor,P-6819,2025-09-16,41,M,Spirituality,DMT,15,Inhaled,Applied a short session with intention setting followed by journaling and clinician guided processing.,4,Patient described a sense of connectedness and increased meaning making. No adverse effects reported beyond transient fatigue.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. L. Patel,P-5542,2025-12-02,72,F,PTSD,Psilocybin,28,Drank,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,4,Patient reported reduced hypervigilance and improved sleep over the next week.,Integration session scheduled in 7 days.\
Dr. E. Chen,P-2394,2025-03-05,33,F,PTSD,Ketamine,66,Injected,Used a monitored ketamine assisted psychotherapy session with vital sign checks and integration afterward.,4,Patient noted fewer intrusive thoughts and a calmer baseline mood.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. M. Hernandez,P-9774,2025-04-10,25,M,Spirituality,DMT,33,Inhaled,Used a brief inhalation session with a sitter present and immediate grounding and integration.,4,Patient reported a deepened meditation practice and reduced existential anxiety.,Integration session scheduled in 7 days.\
Clinician F. Brooks,P-2596,2025-01-24,51,F,Spirituality,DMT,27,Inhaled,Applied a short session with intention setting followed by journaling and clinician guided processing.,2,Patient reported minimal psychological effect and felt frustrated afterward.,Discuss alternative protocol and review safety plan at next visit.\
Dr. R. Nguyen,P-1597,2025-04-06,52,M,PTSD,Psilocybin,35,Eaten,Used a single day guided session with eyeshades and a curated music playlist.,4,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward.,Integration session scheduled in 7 days.\
Dr. K. Johnson,P-2815,2025-06-19,61,F,Addiction,Ketamine,59,Injected,Used a monitored ketamine assisted psychotherapy session with vital sign checks and integration afterward.,4,Patient reported a clear insight into triggers and committed to a relapse prevention plan.,Follow up in 2 weeks to review symptoms and plan next session.\
Clinician B. Jones,P-9982,2025-11-16,24,M,General Personal Health,Psilocybin,37,Drank,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,3,Patient described partial benefit but felt distracted and had difficulty sustaining focus.,Coordinate with primary therapist and reassess in 3 weeks.\
Dr. M. Hernandez,P-5062,2025-06-01,58,F,PTSD,Psilocybin,19,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,2,Patient experienced significant nausea and anxiety and the session ended early. Patient reported GI upset and requested a slower titration approach.,Focus on stabilization and supportive therapy then reconsider in 6 weeks.\
Clinician F. Brooks,P-3683,2025-09-15,73,M,Addiction,Ketamine,86,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,3,Patient reported mild nausea and fatigue which limited depth of processing. Patient remained engaged and completed integration homework.,Coordinate with primary therapist and reassess in 3 weeks.\
Dr. E. Chen,P-6152,2025-07-09,57,M,PTSD,Ketamine,104,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,2,Patient had elevated agitation and required extended grounding and follow up support. Dissociation felt overwhelming and dose will be reconsidered.,Discuss alternative protocol and review safety plan at next visit.\
Dr. S. Kim,P-9793,2025-01-30,46,F,PTSD,Psilocybin,39,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,5,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward. No adverse effects reported beyond transient fatigue.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. L. Patel,P-1316,2025-09-24,62,M,Addiction,Ketamine,112,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,3,Patient reported mild nausea and fatigue which limited depth of processing.,Add additional preparation sessions before considering another treatment.\
Dr. S. Kim,P-4619,2025-05-11,29,F,General Personal Health,Psilocybin,22,Eaten,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,4,Patient described reduced stress reactivity and clearer priorities for self care. No adverse effects reported beyond transient fatigue.,Follow up in 2 weeks to review symptoms and plan next session.\
Clinician D. Allen,P-2013,2025-08-05,55,M,Addiction,Ketamine,43,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,5,Patient reported a clear insight into triggers and committed to a relapse prevention plan. No adverse effects reported beyond transient fatigue.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. L. Patel,P-3965,2025-02-02,21,F,PTSD,Psilocybin,31,Drank,Used a single day guided session with eyeshades and a curated music playlist.,4,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward.,Follow up in 2 weeks to review symptoms and plan next session.\
Clinician F. Brooks,P-2730,2025-12-24,43,M,General Personal Health,Other,127,Injected,Used a protocol focused on safety monitoring and reflective processing after the session.,1,Patient reported minimal psychological effect and felt frustrated afterward.,Medical review scheduled and treatment paused pending reassessment.\
Clinician B. Jones,P-6639,2025-02-22,47,M,General Personal Health,Other,23,Topical,Used a protocol focused on safety monitoring and reflective processing after the session.,3,Patient described partial benefit but felt distracted and had difficulty sustaining focus.,Adjust dose and repeat in 4 weeks if clinically appropriate.\
Dr. E. Chen,P-8653,2025-03-06,64,M,Addiction,Ketamine,109,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,5,Patient reported lower cravings and stronger confidence in maintaining abstinence. No adverse effects reported beyond transient fatigue.,Integration session scheduled in 7 days.\
Dr. S. Kim,P-8649,2025-09-01,34,F,PTSD,Psilocybin,20,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,4,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward. No adverse effects reported beyond transient fatigue.,Integration session scheduled in 7 days.\
Dr. E. Chen,P-3023,2025-12-06,44,F,PTSD,Other,66,Injected,Used a protocol focused on safety monitoring and reflective processing after the session.,3,Patient described partial benefit but felt distracted and had difficulty sustaining focus. Patient remained engaged and completed integration homework.,Coordinate with primary therapist and reassess in 3 weeks.\
Clinician C. Rivera,P-1564,2025-08-24,36,F,General Personal Health,Other,52,Injected,Applied a structured session with symptom tracking and a follow up integration appointment.,4,Patient described reduced stress reactivity and clearer priorities for self care. No adverse effects reported beyond transient fatigue.,Integration session scheduled in 7 days.\
Dr. T. O'Connor,P-7827,2025-06-07,45,M,PTSD,Psilocybin,33,Drank,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,4,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. T. O'Connor,P-7102,2025-02-25,59,F,Addiction,Ketamine,120,Injected,Used a monitored ketamine assisted psychotherapy session with vital sign checks and integration afterward.,4,Patient reported lower cravings and stronger confidence in maintaining abstinence.,Integration session scheduled in 7 days.\
Clinician F. Brooks,P-8099,2025-05-28,70,F,Addiction,Psilocybin,29,Eaten,Used a single day guided session with eyeshades and a curated music playlist.,2,Patient experienced significant nausea and anxiety and the session ended early.,Discuss alternative protocol and review safety plan at next visit.\
Dr. S. Kim,P-1950,2025-05-14,53,M,PTSD,Psilocybin,32,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,5,Patient noted fewer intrusive thoughts and a calmer baseline mood. No adverse effects reported beyond transient fatigue.,Integration session scheduled in 7 days.\
Dr. A. Smith,P-6419,2025-08-30,60,M,PTSD,Psilocybin,16,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,3,Patient described partial benefit but felt distracted and had difficulty sustaining focus.,Add additional preparation sessions before considering another treatment.\
Dr. L. Patel,P-3181,2025-12-13,31,F,General Personal Health,Psilocybin,25,Drank,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,5,Patient reported improved mood and better adherence to health routines.,Integration session scheduled in 7 days.\
Dr. S. Kim,P-3960,2026-01-03,63,M,Addiction,Ketamine,52,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,2,Patient had elevated agitation and required extended grounding and follow up support. Dissociation felt overwhelming and dose will be reconsidered.,Focus on stabilization and supportive therapy then reconsider in 6 weeks.\
Dr. M. Hernandez,P-9777,2025-12-16,27,F,Spirituality,Psilocybin,20,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,4,Patient described a lasting shift in perspective and greater gratitude. No adverse effects reported beyond transient fatigue.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. R. Nguyen,P-9310,2025-06-22,66,M,Spirituality,Psilocybin,36,Drank,Used a single day guided session with eyeshades and a curated music playlist.,4,Patient described a sense of connectedness and increased meaning making. No adverse effects reported beyond transient fatigue.,Follow up in 2 weeks to review symptoms and plan next session.\
Clinician B. Jones,P-4266,2025-08-10,48,M,General Personal Health,Ketamine,74,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,3,Patient reported mild nausea and fatigue which limited depth of processing.,Adjust dose and repeat in 4 weeks if clinically appropriate.\
Clinician C. Rivera,P-2540,2025-10-20,72,F,Addiction,Psilocybin,21,Eaten,Used a single day guided session with eyeshades and a curated music playlist.,4,Patient reported a clear insight into triggers and committed to a relapse prevention plan.,Follow up in 2 weeks to review symptoms and plan next session.\
Dr. T. O'Connor,P-7858,2025-11-27,39,F,General Personal Health,Other,141,Injected,Used a supportive coaching session paired with a standardized preparation and integration plan.,1,Patient reported minimal psychological effect and felt frustrated afterward.,Focus on stabilization and supportive therapy then reconsider in 6 weeks.\
Dr. E. Chen,P-2483,2025-07-02,69,F,PTSD,Psilocybin,30,Eaten,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,4,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward. No adverse effects reported beyond transient fatigue.,Begin weekly therapy and continue daily journaling for 14 days.\
Dr. A. Smith,P-3627,2025-09-06,58,M,PTSD,Ketamine,83,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,5,Patient noted fewer intrusive thoughts and a calmer baseline mood. No adverse effects reported beyond transient fatigue.,Follow up in 2 weeks to review symptoms and plan next session.\
Dr. K. Johnson,P-7924,2025-04-23,22,F,Addiction,Ketamine,63,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,4,Patient described improved impulse control and increased motivation for recovery supports.,Follow up in 2 weeks to review symptoms and plan next session.\
Clinician B. Jones,P-5607,2025-10-12,52,M,General Personal Health,Ketamine,85,Injected,Used a monitored ketamine assisted psychotherapy session with vital sign checks and integration afterward.,2,Patient experienced significant nausea and anxiety and the session ended early. Dissociation felt overwhelming and dose will be reconsidered.,Discuss alternative protocol and review safety plan at next visit.\
Clinician D. Allen,P-3515,2025-05-19,49,F,PTSD,Psilocybin,27,Eaten,Used a single day guided session with eyeshades and a curated music playlist.,5,Patient reported reduced hypervigilance and improved sleep over the next week. No adverse effects reported beyond transient fatigue.,Integration session scheduled in 7 days.\
Dr. R. Nguyen,P-1591,2025-12-28,38,F,Addiction,Ketamine,57,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,4,Patient reported a clear insight into triggers and committed to a relapse prevention plan.,Integration session scheduled in 7 days.\
Dr. M. Hernandez,P-7804,2025-07-23,67,F,Spirituality,DMT,24,Inhaled,Used a brief inhalation session with a sitter present and immediate grounding and integration.,5,Patient described a lasting shift in perspective and greater gratitude.,Follow up in 2 weeks to review symptoms and plan next session.\
Dr. S. Kim,P-2017,2025-03-31,75,M,Addiction,Ketamine,65,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,3,Patient reported mild nausea and fatigue which limited depth of processing. Patient remained engaged and completed integration homework.,Adjust dose and repeat in 4 weeks if clinically appropriate.\
Dr. K. Johnson,P-9858,2025-10-30,63,F,Addiction,Other,105,Eaten,Used a supportive coaching session paired with a standardized preparation and integration plan.,3,Patient reported some insight but noted moderate anxiety during the peak which required coaching. Patient remained engaged and completed integration homework.,Coordinate with primary therapist and reassess in 3 weeks.\
Clinician D. Allen,P-4627,2025-08-09,32,M,PTSD,Psilocybin,24,Eaten,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,2,Patient had elevated agitation and required extended grounding and follow up support. Patient reported GI upset and requested a slower titration approach.,Focus on stabilization and supportive therapy then reconsider in 6 weeks.\
Dr. A. Smith,P-7115,2025-09-26,35,F,PTSD,Ketamine,90,Injected,Applied a structured 2 hour ketamine session with grounding techniques and a short post session reflection.,1,Patient had elevated agitation and required extended grounding and follow up support. Dissociation felt overwhelming and dose will be reconsidered.,Medical review scheduled and treatment paused pending reassessment.\
Dr. R. Nguyen,P-5550,2025-10-06,44,M,PTSD,Psilocybin,40,Drank,Used a supportive setting with breathwork and minimal verbal coaching during the peak.,4,Patient described a meaningful reframe of a traumatic memory and less avoidance afterward.,Integration session scheduled in 7 days.\
Dr. K. Johnson,P-3216,2025-03-02,52,F,Spirituality,Ketamine,93,Injected,Used a monitored ketamine assisted psychotherapy session with vital sign checks and integration afterward.,3,Patient reported some insight but noted moderate anxiety during the peak which required coaching.,Adjust dose and repeat in 4 weeks if clinically appropriate.\
Dr. T. O'Connor,P-2517,2025-11-13,28,Non-Binary,PTSD,Psilocybin,38,Eaten,Applied a preparatory talk then a supervised session followed by a 60 minute integration debrief.,1,Patient reported minimal psychological effect and felt frustrated afterward. Patient reported GI upset and requested a slower titration approach.,Medical review scheduled and treatment paused pending reassessment.\
Dr. M. Hernandez,P-3317,2025-06-15,45,F,Spirituality,DMT,11,Inhaled,Applied a short session with intention setting followed by journaling and clinician guided processing.,4,Patient reported a deepened meditation practice and reduced existential anxiety.,Begin weekly therapy and continue daily journaling for 14 days.\
}